Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6445 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Driving the development of new tools to combat Nipah virus outbreaks

PSI’s Nipah Virus Research Day showcased promising developments, spanning new insights into Nipah virus biology, clinical trials of vaccines, the development of policy responses, and progress in developing diagnostics and treatments, which are helping improve responses to outbreaks of this deadly virus.

Kennedy researchers contribute to UK-wide AI and bioscience training initiative

Together with a group of Oxford researchers, Mark Coles, Professor of Immunology at the Kennedy Institute, will co-lead the Enabling Next-generation AI for a Bioscience-Led Economy (ENAIBLE) initiative.

New study offers breakthrough in detecting risk for psychosis and bipolar disorders

A study published recently in The Lancet Psychiatry has unveiled a new approach to identifying individuals at risk of developing psychotic disorders or bipolar disorder.

A very Mary Christmas: Saving Christmas one cyber step at a time

At this time of year, we are all busy and it’s easy to be distracted, especially when you are trying to get half a billion presents ready. But that’s why it’s especially important to be on the look out for malicious cyber activity – just ask Mary Christmas...

International collaboration launches largest-ever therapeutics trial for patients hospitalised with dengue

A landmark international research collaboration has launched the largest clinical trial ever conducted to test therapeutics for moderate-severe dengue, a mosquito-borne viral disease that continues to spread rapidly driven by climate change and globalisation.

Oxford University and Brazil Ministry of Health Sign Letter of Intent to strengthen cancer care across Brazil

The Ministry of Health of Brazil and Oxford’s Centre for Immuno-Oncology, part of the Nuffield Department of Medicine, have signed a Letter of Intent establishing a broad collaboration to advance cancer research, innovation and clinical translation. The agreement builds on the UK-Brazil Government Health Partnership signed earlier this year, and reflects a shared commitment to accelerating research that will lead to improvements in cancer care across Brazil.

Bodleian Libraries Update - December 2025 - Silent piano | Examination couches | Oxford University Hospitals Book Club and more

Annual GP Tutors Conference 2025: Coming together in connected practice

GP tutors from across the region gathered at St Hilda’s College for the 2025 Nuffield Department of Primary Care Health Sciences GP Tutors Conference, exploring how connected practice can support flourishing and innovation in primary care education.

Special Film Event: ‘Breaking the Mould’ – Saturday 31 January 2026

MSD Research Staff Forum update - Supporting career paths for researchers

MSD Alumni Comms and Engagement Meeting

Oxford cancer researchers welcome UK AI for Science Strategy, highlighting the opportunity for national AI-ready cancer data

Oxford researchers have welcomed the UK government’s new AI for Science Strategy, which sets out an ambitious plan to harness artificial intelligence, sovereign supercomputing and high-quality scientific data to accelerate discovery in the life sciences.

Cognitive impairment after a stroke calls for tailored recovery treatment shows new study

A major new study recently published in Imaging Neuroscience shows that the brain location of the stroke does not always determine the symptoms.

Simple scoring system could help clinicians identify possible cases of NMDAR-antibody encephalitis

Scientists from across Oxford have identified a key set of symptoms and developed a scoring system to help clinicians in frontline medical and mental health services consider the possibility of a rare form of encephalitis, which can sometimes be mistaken for psychosis.

Simple steps for REF open access

REF Unpaused

Medical Sciences Internal Fund: opportunity to join the MSD Review Panel

New research collaboration to tackle ethnic inequalities in perinatal severe mental illness

A ground-breaking new study aims to transform postpartum mental health care for mothers from ethnic minority backgrounds or those living in deprived areas who experience severe mental illness.

Oxford researchers develop first live-cell assay linking cancer tumour metabolism to drug effectiveness

Scientists at the Centre for Medicines Discovery, part of Oxford University’s Nuffield Department of Medicine, have developed a biosensor that, for the first time, allows researchers to directly measure how experimental cancer drugs engage their target inside living cells dependent on co-factors and metabolites.

World-leading researchers unite for ‘pivotal’ study to help children and adults with arthritis to live drug free

The prospect of long-lasting drug-free remission for children and adults living with inflammatory arthritis is a step closer to becoming a reality, thanks to a new collaboration which includes world-leading researchers from the Kennedy Institute.

Load More